Evidence map›Paper›PMID 21778411›Full record

ArticleAmerican journal of respiratory cell and molecular biology2012

The tobacco smoke component, acrolein, suppresses innate macrophage responses by direct alkylation of c-Jun N-terminal kinase.

Milena Hristova, Page C Spiess, David I Kasahara, Matthew J Randall, Bin Deng, Albert van der Vliet

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 40 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Origin and Fate of Acrolein in Foods.Foods (Basel, Switzerland) · 2022
    Review
  5. Review
  6. Preventive effect ofF1000Research · 2021
    Article
  7. Smoking-induced iron dysregulation in the lung.Free radical biology & medicine · 2019
    Review
  8. Article
  9. Alda-1 Protects Against Acrolein-Induced Acute Lung Injury and Endothelial Barrier Dysfunction.American journal of respiratory cell and molecular biology · 2017
    Article
  10. Article
  11. Review
  12. Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine.Toxicology in vitro : an international journal published in association with BIBRA · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Molecular mechanisms of acrolein toxicity: relevance to human disease.Toxicological sciences : an official journal of the Society of Toxicology · 2015
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Milena HristovaDepartment of Pathology, College of Medicine, University of Vermont, Burlington, 05405, USA.
Page C Spiess
David I Kasahara
Matthew J Randall
Bin Deng
Albert van der Vliet
University of Vermont · US

Funding

VOLATILE SIGNALING IN PHARBITIS NILP20RR016462 · NCRR · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI KIRSHENBAUM, ARI PHILLIP · 2001 to 2011
$31.1M
Dual Oxidase in Airway Epithelial Repair and RemodelingR01HL085646 · NHLBI · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2008 to 2020
$4.7M
ENVIRONMENTAL PATHOLOGY TRAINING PROGRAMT32ES007122 · NIEHS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 1985 to 2012
$4.2M
Cigarette Smoke-derived Electrophilic Aldehydes and Airway InflammationR01ES021476 · NIEHS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2012 to 2016
$1.9M
TOXIC ALDEHYDES AS MODULATORS OF LUNG INFLAMMATIONR01HL068865 · NHLBI · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI VAN DER VLIET, ALBERT · 2003 to 2007
$1.5M
NCRR NIH HHS P20 RR016462NCRR NIH HHS P20RR016462NHLBI NIH HHS HL068865NHLBI NIH HHS HL085646NHLBI NIH HHS R01 HL068865NHLBI NIH HHS R01 HL085646NIEHS NIH HHS ES007122NIEHS NIH HHS R01 ES021476NIEHS NIH HHS T32 ES007122
6 · The paper itself

Abstract

The respiratory innate immune system is often compromised by tobacco smoke exposure, and previous studies have indicated that acrolein, a reactive electrophile in tobacco smoke, may contribute to the immunosuppressive effects of smoking. Exposure of mice to acrolein at concentrations similar to those in cigarette smoke (5 ppm, 4 h) significantly suppressed alveolar macrophage responses to bacterial LPS, indicated by reduced induction of nitric oxide synthase 2, TNF-α, and IL-12p40. Mechanistic studies with bone marrow-derived macrophages or MH-S macrophages demonstrated that acrolein (1-30 μM) attenuated these LPS-mediated innate responses in association with depletion of cellular glutathione, although glutathione depletion itself was not fully responsible for these immunosuppressive effects. Inhibitory actions of acrolein were most prominent after acute exposure (<2 h), indicating the involvement of direct and reversible interactions of acrolein with critical signaling pathways. Among the key signaling pathways involved in innate macrophage responses, acrolein marginally affected LPS-mediated activation of nuclear factor (NF)-κB, and significantly suppressed phosphorylation of c-Jun N-terminal kinase (JNK) and activation of c-Jun. Using biotin hydrazide labeling, NF-κB RelA and p50, as well as JNK2, a critical mediator of innate macrophage responses, were revealed as direct targets for alkylation by acrolein. Mass spectrometry analysis of acrolein-modified recombinant JNK2 indicated adduction to Cys(41) and Cys(177), putative important sites involved in mitogen-activated protein kinase (MAPK) kinase (MEK) binding and JNK2 phosphorylation. Our findings indicate that direct alkylation of JNK2 by electrophiles, such as acrolein, may be a prominent and hitherto unrecognized mechanism in their immunosuppressive effects, and may be a major factor in smoking-induced effects on the immune system.

Indexed as

AcroleinAlkylationAnimalsHumansImmunity, InnateImmunosuppressive AgentsInterleukin-12 Subunit p40JNK Mitogen-Activated Protein KinasesLipopolysaccharidesMacrophagesMaleMiceMice, Inbred C57BLMitogen-Activated Protein Kinase 9Mitogen-Activated Protein Kinase KinasesNF-kappa BAcroleinImmunosuppressive AgentsInterleukin-12 Subunit p40JNK Mitogen-Activated Protein KinasesLipopolysaccharidesMitogen-Activated Protein Kinase 9Mitogen-Activated Protein Kinase KinasesNF-kappa BNitric Oxide Synthase Type IISmokeTumor Necrosis Factor-alpha

Identifiers

PMID21778411
PMCPMC3262655
OpenAlexW2151254618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.